Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects

scientific article published on 01 January 1994

Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3109/02841869409121782
P698PubMed publication ID7946448

P2093author name stringH Blomgren
I Lax
I Näslund
R Svanström
P433issue6
P304page(s)677-683
P577publication date1994-01-01
P1433published inActa OncologicaQ326164
P1476titleStereotactic radiotherapy of malignancies in the abdomen. Methodological aspects
P478volume33

Reverse relations

cites work (P2860)
Q38428533(Radio)biological optimization of external-beam radiotherapy
Q419109224D digitally reconstructed radiography for verifying a lung tumor position during volumetric modulated arc therapy
Q374170994DCT and CBCT based PTV margin in Stereotactic Body Radiotherapy(SBRT) of non-small cell lung tumor adhered to chest wall or diaphragm
Q92888822A Magnetic Resonance Compatible E4D Ultrasound Probe for Motion Management of Radiation Therapy
Q35862313A Survey of Stereotactic Body Radiotherapy in Korea
Q30931923A note from history: Landmarks in history of cancer, part 7.
Q44011535A prospective study of quality of life including fatigue and pulmonary function after stereotactic body radiotherapy for medically inoperable early-stage lung cancer
Q36420968A retrospective study of SBRT of metastases in patients with primary sarcoma
Q39771088A survey of stereotactic body radiotherapy use in the United States
Q38790915A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer
Q35625039Accuracy of image guidance using free-breathing cone-beam computed tomography for stereotactic lung radiotherapy
Q35684123Advanced radiation treatment planning and delivery approaches for treatment of lung cancer
Q58804831Advances in the use of motion management and image guidance in radiation therapy treatment for lung cancer
Q35200644Alternatives to surgery in early stage disease-stereotactic body radiotherapy
Q24595548An Orthotopic Lung Tumor Model for Image-Guided Microirradiation in Rats
Q61810098An alternative approach to GTV margin determination in stereotactic body radiotherapy
Q92159160Beyond T2 and 3T: New MRI techniques for clinicians
Q53659652CT image-guided intensity-modulated therapy for paraspinal tumors using stereotactic immobilization.
Q38433307Cardiac embolization of an implanted fiducial marker for hepatic stereotactic body radiotherapy: a case report
Q53807656Clinical outcome of stereotactic body radiotherapy of 54 Gy in nine fractions for patients with localized lung tumor using a custom-made immobilization system.
Q48627050Commissioning and quality assurance of a commercial stereotactic treatment-planning system for extracranial IMRT.
Q50578610Comprehensive dosimetric planning comparison for early-stage, non-small cell lung cancer with SABR: fixed-beam IMRT versus VMAT versus TomoTherapy.
Q73174088Conformal radiotherapy of challenging paraspinal tumors using a multiple arc segment technique
Q38421253Contemporary treatment with radiosurgery for spine metastasis and spinal cord compression in 2015.
Q82606652Curative stereotactic body radiotherapy for liver malignancy
Q37468265Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer
Q44864095Determining the optimal block margin on the planning target volume for extracranial stereotactic radiotherapy
Q60908706Developments in Stereotactic Body Radiotherapy
Q73269164Dynamic conical conformal radiotherapy using a C-arm–mounted accelerator: dose distribution and clinical application
Q41475564Emerging Therapies for Stage III Non-Small Cell Lung Cancer: Stereotactic Body Radiation Therapy and Immunotherapy
Q57805629Estimation of the risk for radiation-induced liver disease following photon- or proton-beam radiosurgery of liver metastases
Q48604650Evaluation of initial setup errors of two immobilization devices for lung stereotactic body radiation therapy (SBRT).
Q36980782Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial
Q31861541Extracranial radiosurgery: immobilizing liver motion in dogs using high-frequency jet ventilation and total intravenous anesthesia
Q73415840Extracranial stereotactic radiation therapy: set-up accuracy of patients treated for liver metastases
Q78949913Extracranial stereotactic radiotherapy: evaluation of PTV coverage and dose conformity
Q35059547Feasibility of deformation-independent tumor-tracking radiotherapy during respiration
Q34807230Future directions for cryosurgery computer treatment planning
Q35599955Hypofractionated stereotactic radiotherapy for primary and secondary intrapulmonary tumors: first results of a phase I/II study
Q35106916Image guidance for precise conformal radiotherapy
Q39296804Imaged-guided liver stereotactic body radiotherapy using VMAT and real-time adaptive tumor gating. Concerns about technique and preliminary clinical results.
Q51681326Impact of target reproducibility on tumor dose in stereotactic radiotherapy of targets in the lung and liver.
Q50016239Improvement of conformal arc plans by using deformable margin delineation method for stereotactic lung radiotherapy.
Q42607027Individually optimized stereotactic radiotherapy for pancreatic head tumors: A planning feasibility study.
Q34717651Innovations in image-guided radiotherapy.
Q50324017Institutional experience in the treatment of colorectal liver metastases with stereotactic body radiation therapy
Q34567594Interfraction Liver Shape Variability and Impact on GTV Position During Liver Stereotactic Radiotherapy Using Abdominal Compression
Q74272935Intrafractional tumor position stability during computed tomography (CT)-guided frameless stereotactic radiation therapy for lung or liver cancers with a fusion of CT and linear accelerator (FOCAL) unit
Q36027055Is England closing the international gap in cancer survival?
Q39677743Klatskin tumor treated by inter-disciplinary therapies including stereotactic radiotherapy: a case report
Q26738869Liver-Directed Radiotherapy for Hepatocellular Carcinoma
Q53063955Lung and liver SBRT using helical tomotherapy--a dosimetric comparison of fixed jaw and dynamic jaw delivery.
Q33603813Management of three-dimensional intrafraction motion through real-time DMLC tracking
Q74272946Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumors: original research in the treatment of thoracic neoplasms
Q26849767Minimally invasive local treatments for bone and pulmonary metastases
Q97587469Modern therapeutic approaches for the treatment of malignant liver tumours
Q38475530Multimedia educational services in stereotactic radiotherapy
Q39666576Near simultaneous computed tomography image-guided stereotactic spinal radiotherapy: an emerging paradigm for achieving true stereotaxy
Q52595063Non-invasive Cardiac Radiation for Ablation of Ventricular Tachycardia: a New Therapeutic Paradigm in Electrophysiology.
Q72992603Noninvasive patient fixation for extracranial stereotactic radiotherapy
Q33778271Novel application of stereotactic ablative radiotherapy using CyberKnife(®) for early-stage renal cell carcinoma in patients with pre-existing chronic kidney disease: Initial clinical experiences
Q53672257Numerical algorithms for spatial registration of line fiducials from cross-sectional images.
Q61804648Optimizing immobilization, margins, and imaging for lung stereotactic body radiation therapy
Q57482034Performance evaluation and first clinical experience with the Varian RGSC module for breath detection of 15 lung cancer patients
Q46240820Performance of dose calculation algorithms from three generations in lung SBRT: comparison with full Monte Carlo-based dose distributions
Q51778319Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma.
Q73611570Preliminary study of stereotactic radiotherapy for lung cancer
Q26851601Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients
Q49189263Proton Grid Therapy.
Q47142130Quality and safety in stereotactic radiosurgery and stereotactic body radiation therapy: can more be done?
Q34005194Radiation therapy for liver tumors: ready for inclusion in guidelines?
Q47714442Radiobiological analysis of stereotactic body radiation therapy for an evidence-based planning target volume of the lung using multiphase CT images obtained with a pneumatic abdominal compression apparatus: a case study
Q57875955Radiothérapie en conditions stéréotaxiques des patients inopérables
Q50297707Renal Cell Carcinoma in von Hippel-Lindau Disease-From Tumor Genetics to Novel Therapeutic Strategies
Q36938199Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma.
Q47869234Role and Future Directions of External Beam Radiotherapy for Primary Liver Cancer
Q37487162Role of stereotactic body radiotherapy in the management of primary hepatocellular carcinoma. Rationale, technique and results
Q35200592SBRT in operable early stage lung cancer patients.
Q47229792Selecting beam weight and wedge filter on the basis of dose gradient analysis
Q98292839Single-Fraction Stereotactic Body Radiation Therapy: A Paradigm During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond?
Q51703632Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas.
Q71783537Stereotactic High Dose Fraction Radiation Therapy of Extracranial Tumors Using An Accelerator: Clinical experience of the first thirty-one patients
Q47841280Stereotactic IMRT for prostate cancer: setup accuracy of a new stereotactic body localization system
Q64246266Stereotactic Radiotherapy for Oligometastasis
Q44462016Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung
Q83674166Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer
Q36360066Stereotactic body radiation therapy for abdominal oligometastases: a biological and clinical review.
Q34859171Stereotactic body radiation therapy is effective and safe in patients with early-stage non-small cell lung cancer with low performance status and severe comorbidity
Q38046079Stereotactic body radiotherapy treatment of extracranial metastases
Q35108961Stereotactic body radiotherapy-induced arterial hypervascularity of non-tumorous hepatic parenchyma in patients with hepatocellular carcinoma: potential pitfalls in tumor response evaluation on multiphase computed tomography
Q36415585Stereotactic conformal radiotherapy of hepatic metastases:clinical analysis of 8 cases
Q37970957Stereotactic radiotherapy in the liver hilum. Basis for future studies
Q73131153Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame
Q33706721Strategies to tackle the challenges of external beam radiotherapy for liver tumors
Q89988131Technology-driven research for radiotherapy innovation
Q42289620The advantage of iron-containing fiducial markers placed with a thin needle for radiotherapy of liver cancer in terms of visualization on MRI: an initial experience of Gold Anchor.
Q74107215The effectiveness of an immobilization device in conformal radiotherapy for lung tumor: reduction of respiratory tumor movement and evaluation of the daily setup accuracy
Q35939730The evolving role of stereotactic radiosurgery and stereotactic radiation therapy for patients with spine tumors
Q47734152The impact of technology on the changing practice of lung SBRT.
Q39586910The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy
Q37743289The role of stereotactic body radiotherapy in the management of non-small cell lung cancer: an emerging standard for the medically inoperable patient?
Q38214799The role of stereotactic radiotherapy in the treatment of oligometastases
Q39068310The role of technology in clinical trials using stereotactic body radiotherapy
Q90407151Three discipline collaborative radiation therapy (3DCRT) special debate: The single most important factor in determining the future of SBRT is immune response
Q37278431To gate or not to gate - dosimetric evaluation comparing Gated vs. ITV-based methodologies in stereotactic ablative body radiotherapy (SABR) treatment of lung cancer
Q42098921Treatment fractionation for stereotactic radiotherapy of lung tumours: a modelling study of the influence of chronic and acute hypoxia on tumour control probability
Q50766094Ultrasound-guided extracranial radiosurgery: technique and application.
Q50552492Undetectable late hepatic sequelae after hypofractionated stereotactic radiotherapy for liver tumors.
Q73206488[Conformal radiotherapy: principles and classification]
Q79987131[Stereotactic irradiation of lung tumors]
Q81721571[Stereotactic radiation therapy for liver metastases]
Q77335642[The point of view of the radiotherapist]

Search more.